Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases
Implementing Organization
Indian Institute of Chemical Engineers
Indian Institute of Chemical Technology (IICT)
About
Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.
Patents
CN102348482, EP2379175, US8816109
Outcome / Output
The process involves
: Preparation of Myristoleic acid from oleic/undecenoic acid
, Transesterification of Myristoleic acid with cetyl alcohol to obtain cetyl myristoleate isomers
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Indian Institute of Chemical Engineers
Acces sibility Controls